PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
07-Jun-2021 Learn About Available Programs that Provide Backup Power and Lessen the Impact of a Public Safety Power Shutoff Businesswire
07-Jun-2021 Clinical AI Technology Leader Mendel Raises $18M in New Capital Businesswire
07-Jun-2021 PerkinElmer Supports JUMP-CP Consortium Creating World’s Largest, Public Cell Painting Dataset Businesswire
07-Jun-2021 Entegris Expands Life Sciences Production Capacity and Capabilities Businesswire
07-Jun-2021 Cardiac Insight Awarded Wearable Medical Devices and Mobile Medical Applications Category Group Purchasing Agreement with Premier Businesswire
07-Jun-2021 The Results of a Preclinical Trial Demonstrating the Benefits of Inhaled Pherecydes Pharma Phages in Treating Ventilation-associated Pneumonia Have Been Published in the Prestigious British Journal of Pharmacology Businesswire
07-Jun-2021 Osel Announces Positive Results from Phase 1b Trial of Live Biotherapeutic Product CBM588 in Combination with Checkpoint Inhibitor (CPI) Therapy in Metastatic Renal Cell Carcinoma Businesswire
07-Jun-2021 Valbiotis Appoints Sébastien Bessy, International Expert in Consumer Healthcare, as Chief Operating Marketing and Business Officer Businesswire
07-Jun-2021 QPharma Launches Neolytica, an AI focused Healthcare Analytics Firm Businesswire
07-Jun-2021 Seven and Eight Biopharma’s BDB001 in Combination with Pembrolizumab Shows Favorable Safety and Clinical Responses in Interim Phase 1 Data Presented at the 2021 ASCO Annual Meeting Businesswire
07-Jun-2021 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Rekor Systems, Inc. (REKR) on Behalf of Investors Businesswire
07-Jun-2021 Atara Biotherapeutics Presents Positive Tab-cel® Long-Term Overall Survival Data for Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease After Solid Organ Transplant at ATC 2021 Virtual Connect Businesswire
07-Jun-2021 Lennham Pharmaceuticals Announces Topline Results from Pharmacokinetic Study of d9-Caffeine Versus Caffeine Businesswire
07-Jun-2021 MyMD Pharmaceuticals Set to Join Russell Microcap® Index Businesswire
07-Jun-2021 The Scottish Medicines Consortium (SMC) Accepts Kyowa Kirin’s POTELIGEO® (mogamulizumab) for the Treatment of Those Living With Certain Ultra-rare Blood Cancers Businesswire
07-Jun-2021 Mirum Pharmaceuticals Appoints Veteran Biotechnology Executive Carol L. Brosgart, M.D. to Board of Directors Businesswire
07-Jun-2021 Humanigen Announces Ken Trbovich Appointed as Senior Vice President, Investor Relations Businesswire
07-Jun-2021 Exelixis and Ipsen Announce Detailed Results from Phase 3 COSMIC-311 Pivotal Trial of Cabozantinib in Patients with Previously Treated Radioactive Iodine-Refractory Differentiated Thyroid Cancer Presented at ASCO 2021 Businesswire
07-Jun-2021 Amneal Announces Dihydroergotamine (DHE) Autoinjector NDA for Migraines and Cluster Headaches Businesswire
07-Jun-2021 Exelixis and Ipsen Announce Detailed Results from Phase 3 COSMIC-311 Pivotal Trial of Cabozantinib in Patients with Previously Treated Radioactive Iodine-Refractory Differentiated Thyroid Cancer Presented at ASCO 2021 Businesswire